The structure of a new cardenolide diglycoside and the biological activities of eleven cardenolide diglycosides from Nerium oleander

  • Zhao Ming
    College of Chemistry and Chemical Engineering, Qiqihar University
  • Bai Liming
    College of Chemistry and Chemical Engineering, Qiqihar University
  • Toki Asami
    Graduate School of Science and Technology, Niigata University
  • Hasegawa Ryo
    Graduate School of Science and Technology, Niigata University
  • Sakai Jun-ichi
    Department of Chemistry and Chemical Engineering, Faculty of Engineering, Niigata University
  • Hasegawa Toshiaki
    Mitsubishi Gas Chemical Company, Inc., Niigata Research Laboratory
  • Ogura Hirotsugu
    Center for Biological Resources and Informatics, Tokyo Institute of Technology
  • Kataoka Takao
    Center for Biological Resources and Informatics, Tokyo Institute of Technology
  • Bai Yuhua
    Department of Medicinal Chemistry, Pharmaceutical Department, Daqing Campus of Harbin Medical University
  • Ando Mariko
    Technical Division, School of Engineering, Tohoku University
  • Hirose Katsutoshi
    KNC Laboratories Co., Ltd.
  • Ando Masayoshi
    Department of Chemistry and Chemical Engineering, Faculty of Engineering, Niigata University

書誌事項

タイトル別名
  • The Structure of a New Cardenolide Diglycoside and the Biological Activities of Eleven Cardenolide Diglycosides from <i>Nerium oleander</i>

この論文をさがす

抄録

A new cardenolide diglycoside (1) was isolated from Nerium oleander together with ten known cardenolide diglycosides 211. The structure of compound 1 was established on the basis of their spectroscopic data. The in vitro anti-inflammatory activity of compounds 111 was examined on the basis of inhibitory activity against the induction of the intercellular adhesion molecule-1 (ICAM-1). Compounds 25 were active at an IC50 value of less than 0.8 μM. The cytotoxicity of compounds 111 was evaluated against three human cell lines normal human fibroblast cells (WI-38), malignant tumor cells induced from WI-38 (VA-13), and human liver tumor cells (HepG2). Compound 3 was active toward VA-13 cells, and compounds 25 were active toward HepG2 cells at IC50 values of less than 1.3 μM. The multidrug resistance (MDR)-reversal activity of compounds 111 was evaluated on the basis of the amount of calcein in MDR human ovarian cancer 2780AD cells in the presence of each compound. Compounds 1 and 8 showed moderate effects on calcein accumulation.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (27)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ